Antineoplastic Agents

Antineoplastic Agents Companies (25)

Antineoplastic Agents Products (125)

  • Product ANTI CANCER CISPLATIN 10MG/ 10ML, 10MG/20ML, 50MG/100ML, 50MG/50ML, 100 MG/50ML

    Cisplatin is a cytotoxic platinum-based compound that exerts its antineoplastic effect by crosslinking DNA, thereby inhibiting DNA replication and transcription in rapidly dividing cells. This DNA damage activates repair pathways and ultimately induces apoptosis if repair fails. Only the cis-isomer is...
  • Product Pembrolizumab

    Pembrolizumab is an anti-PD-1 mAb with the broadest approved indication portfolio globally. Spanning NSCLC first-line to MSI-H/TMB-H pan-tumor indications, it represents the absolute benchmark in immuno-oncology with an exceptionally high market ceiling.
  • Product Pembrolizumab 100 mg/4 ml

    Description: Sterile injectable formulation of pembrolizumab, a monoclonal antibody used in immunotherapy. It enhances the body’s immune response against tumor cells by targeting immune checkpoint pathways. Commonly used in the treatment of various cancers, including melanoma, lung cancer, and other advan...
  • Product Pemetrexed disodium

    Carelife offers a wide range of products which includes Clindamycin Hydrochloride, Phosphate, Palmitate Hydrochloride. 

     We also offer:  

    Iron sucrose
    Ferric carboxymaltose
    Pemetrexed disodium
    Granisetron HCl
    Mitoxantrone HCl...
  • Product Leuprorelin Acetate

    Treatment of endometriosis, uterine fibroids, prostate cancer, and central precocious puberty.

  • Product NADPH

    NADPH is a phosphorylated derivative of the 2' -position of the ribose ring system linked to adenine dinucleotide of nicotinamide (NAD+), which is involved in many anabolic reactions. NADPH is a kind of coenzyme, called reduced coenzyme II, the scientific name is reduced nicotinamide adenine dinucleot...
  • Product Naprod Product List

    General LyophilizedGeneral Liquid
    Onco Liquid
    Onco lyophilized
    Onco OSD
  • Product Docetaxel Injection

    Strength: 20mg : 1mL; 80mg : 4mL
    Packaging: vial
    Indication: for the treatment of breast cancer, non-small cell lung cancer, prostate cancer, gastric cancer, and head and neck cancer, as monotherapy or in combination regimens as appropriate.
    Status: US FDA approved
  • Product Carfilzomib

    Carfilzomib for Injection (available in 10 mg, 30 mg, and 60 mg single-dose vials) is a prescription-strength, second-generation proteasome inhibitor formulated to treat advanced hematologic malignancies. Delivered as a sterile, preservative-free lyophilized (freeze-dried) powder cake, it acts as an irreve...
  • Product Icotinib Hydrochloride

    Antineoplastic Agents
  • Product Neutromax 30 M I.U./ 48 M I.U.

    Filgrastim is a recombinant methionyl human granulocyte colony stimulating factor (r-Met-Hu-GCSF), produced by bacterial fermentation. Filgrastim is used to treat neutropenia, a side effect of chemotherapy, which makes patients more susceptible to bacterial infections.
    Biosidus Filgrastim product is av...
  • Product Oxaliplatin SEDICO vials

    Treat certain cancers, especially colorectal (colon and rectal) cancer.
  • Product Flupentixol Dihydrochloride BP/EP

    Flupentixol Dihydrochloride is an antipsychotic medication belonging to the thioxanthene class. It is primarily used to treat schizophrenia and other mental health disorders, including depression.

    Mechanism of Action:

    Alters the balance of neurotransmitters in the brain, parti...
  • Product APIs

    • Paclitaxel (Package : Up to 500g Per request) • Pemetrexed (Package : Up to 1kg Per request) • Bortezomib (Package : Up to 40g Per request)
  • Product Lenvatinib Mesilate Capsules

    This product is suitable for patients with unresectable hepatocellular carcinoma who have not previously received systemic therapy.The pivotal study of lenvatinib mesylate excluded patients with HCC amenable to local therapy, for whom no study data are available. 
  • Product Erlotinib

    Erlotinib is an oral epidermal growth factor receptor tyrosine kinase inhibitor that helps inhibit signalling pathways associated with tumour-cell proliferation and survival. It is available as 100 mg and 150 mg tablets in packs of 30, providing strength options for standard treatment and dose adjustment r...
  • Product Finished formulation for General products and Oncology products

    Finished formulation for General products and Oncology products 

    Formulations available in 
    -- Tablets 
    -- Capsules 
    -- Dry powder for suspension 


    Products packed in 
    -- Blister pack
    -- Drum pack 
    -- Bottle Pack
    -- Sachet 

Upcoming Events

  • CPHI Korea 2026

    COEX, Seoul, Korea
    25 Aug 2026 - 27 Aug 2026
  • CPHI & PMEC Shenzhen 2026

    Shenzhen Convention & Exhibition Center (SZCEC), China
    16 Sep 2026 - 18 Sep 2026
  • CPHI Milan 2026

    Fiera Milano, Italy
    6 Oct 2026 - 8 Oct 2026

Pharmaceutical Industry Webinars